Abstract
Clinical sequelae and symptoms for a considerable number of COVID-19 patients can linger for months beyond the acute stage of SARS-CoV-2 infection, “long COVID”. Among the long-term consequences of SARS-CoV-2 infection, cognitive issues (especially memory loss or “brain fog”), chronic fatigue, myalgia, and muscular weakness resembling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are of importance. Melatonin may be particularly effective at reducing the signs and symptoms of SARS-CoV-2 infection due to its functions as an antioxidant, anti-inflammatory, and immuno-modulatory agent. Melatonin is also a chronobiotic medication effective in treating delirium and restoring the circadian imbalance seen in COVID patients in the intensive care unit. Additionally, as a cytoprotector, melatonin aids in the prevention of several COVID-19 comorbidities, including diabetes, metabolic syndrome, and ischemic and non-ischemic cardiovascular diseases. This narrative review discusses the application of melatonin as a neuroprotective agent to control cognitive deterioration (“brain fog”) and pain in the ME/CFS syndrome-like documented in long COVID. Further studies on the therapeutic use of melatonin in the neurological sequelae of SARS-CoV-2 infection are warranted.
Subject
Molecular Biology,Biochemistry
Reference94 articles.
1. Center for Systems Science and Engineering (CSSE) 2022 COVID-19 Map—Johns Hopkins Coronavirus Resource Center. 2022.
2. Neurological Sequelae of COVID-19;Ahmad;J. Integr. Neurosci.,2022
3. Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection;Hope;Infect. Dis. Clin. N. Am.,2022
4. Long COVID after Breakthrough SARS-CoV-2 Infection;Al-Aly;Nat. Med.,2022
5. A Systematic Review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant;Zhang;Int. J. Biol. Sci.,2022
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献